Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 4993-4998, September 15, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trikha, M.
Right arrow Articles by Markland, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trikha, M.
Right arrow Articles by Markland, F. S.

Contortrostatin, a Snake Venom Disintegrin, Inhibits ß1 Integrin-mediated Human Metastatic Melanoma Cell Adhesion and Blocks Experimental Metastasis1

Mohit Trikha, Yves A. De Clerck and Francis S. Markland2

Department of Biochemistry and Molecular Biology and University of Southern California Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90033

Disintegrins are Arg-Gly-Asp-containing proteins that inhibit integrin-mediated cell-cell and cell-matrix interactions. We have purified a disintegrin, contortrostatin, from Agkistrodon contortrix contortrix snake venom that is a potent inhibitor of human metastatic melanoma (M24 met) cell adhesion to extracellular matrix proteins. Contortrostatin inhibits M24 met cell adhesion to type I collagen, vitronectin, and fibronectin with 50% inhibitory concentration values of 20, 75, and 220 nM, respectively. Contortrostatin does not significantly inhibit adhesion of M24 met cells to laminin. 125I-labeled contortrostatin binds to M24 met cells in a saturable and displaceable manner. Scatchard analysis indicates that there are two binding sites for 125I-labeled contortrostatin on the surface of these cells. High affinity binding has a Kd of 3 nM with 165,000 sites/cell; low affinity binding has a Kd of 60 nM with 500,000 sites/cell. Immobilized contortrostatin can support adhesion of M24 met cells; this binding is blocked by a monoclonal antibody to the ß1 integrin subunit and by an antibody to the fibronectin receptor {alpha}5ß1. The anti-vitronectin receptor ({alpha}vß5) monoclonal antibody which blocks adhesion of M24 met cells to immobilized vitronectin does not block binding of M24 met cells to immobilized contortrostatin. In an in vivo experimental metastasis model system, contortrostatin at 20 µg and 100 µg inhibits lung colonization of M24 met cells (5 x 105), injected in the tail vein of scid mice, by 51 and 73%, respectively. We conclude that contortrostatin is a potent inhibitor of ß1 integrin-mediated M24 met cell adhesion in vitro and that it also inhibits lung colonization in vivo.

1 This work was supported by NIH Department of Health and Human Services Grants CA54861 (F. S. M., Y. A. D.) and CA42919 (Y. A. D).

2 To whom requests for reprints should be addressed, at University of Southern California School of Medicine, Cancer Research Laboratory #106, 1303 North Mission Road, Los Angeles, CA 90033.

Received 2/ 3/94. Accepted 7/20/94.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. Edderkaoui, P. Hong, J. K. Lee, S. J. Pandol, and A. S. Gukovskaya
Insulin-like Growth Factor-I Receptor Mediates the Prosurvival Effect of Fibronectin
J. Biol. Chem., September 14, 2007; 282(37): 26646 - 26655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
E. Oxelmark, J. M. Roth, P. C. Brooks, S. E. Braunstein, R. J. Schneider, and M. J. Garabedian
The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and Invasion.
Mol. Cell. Biol., July 1, 2006; 26(14): 5205 - 5213.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. R. Cominetti, C. H. B. Terruggi, O. H. P. Ramos, J. W. Fox, A. Mariano-Oliveira, M. S. De Freitas, C. C. Figueiredo, V. Morandi, and H. S. Selistre-de-Araujo
Alternagin-C, a Disintegrin-like Protein, Induces Vascular Endothelial Cell Growth Factor (VEGF) Expression and Endothelial Cell Proliferation in Vitro
J. Biol. Chem., April 30, 2004; 279(18): 18247 - 18255.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Swenson, F. Costa, R. Minea, R. P. Sherwin, W. Ernst, G. Fujii, D. Yang, and F. S. Markland Jr.
Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression
Mol. Cancer Ther., April 1, 2004; 3(4): 499 - 511.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Palmantier, M. D. George, S. K. Akiyama, F. M. Wolber, K. Olden, and J. D. Roberts
cis-Polyunsaturated Fatty Acids Stimulate {beta}1 Integrin-mediated Adhesion ofHuman Breast Carcinoma Cells to Type IV Collagen by Activating ProteinKinases C-{{epsilon}} and -{micro}
Cancer Res., March 1, 2001; 61(6): 2445 - 2452.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
I.-C. Kang, Y.-D. Lee, and D.-S. Kim
A Novel Disintegrin Salmosin Inhibits Tumor Angiogenesis
Cancer Res., August 1, 1999; 59(15): 3754 - 3760.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Marcinkiewicz, J. J. Calvete, M. M. Marcinkiewicz, M. Raida, S. Vijay-Kumar, Z. Huang, R. R. Lobb, and S. Niewiarowski
EC3, a Novel Heterodimeric Disintegrin from Echis carinatus Venom, Inhibits alpha 4 and alpha 5 Integrins in an RGD-independent Manner
J. Biol. Chem., April 30, 1999; 274(18): 12468 - 12473.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
F. Johnson and B. Shur
The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells
J. Cell Sci., January 8, 1999; 112(16): 2785 - 2795.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.